In addition, significantly downregulated serum IL-17 levels in our cohort of SLE patients is in contrast with the findings of elevated serum IL-17 levels in SLE patients as reported previously (22–24, 26). This evidence concerns the gene IL17A and systemic lupus erythematosus.